<table width="100%" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<caption>Table 7: Effect of Efavirenz on Coadministered Drug Plasma C<sub>max</sub>, AUC, and C<sub>min</sub>
</caption>
<col width="22%"></col>
<col width="18%"></col>
<col width="15%"></col>
<col width="9%"></col>
<col width="12%"></col>
<col width="12%"></col>
<col width="12%"></col>
<tfoot>
<tr>
<td align="left" colspan="7" stylecode="Botrule" valign="top">↑ Indicates increase    ↓ Indicates decrease   ↔  Indicates no change or a mean increase or decrease of &lt;10%.<br/>
<sup>a</sup>  Compared with atazanavir 400 mg qd alone.<br/>
<sup>b</sup>  Comparator dose of indinavir was 800 mg q8h × 10 days.<br/>
<sup>c</sup>  Parallel-group design; n for efavirenz + lopinavir/ritonavir, n for lopinavir/ritonavir alone.<br/>
<sup>d</sup>  Values are for lopinavir; the pharmacokinetics of ritonavir in this study were unaffected by concurrent efavirenz.<br/>
<sup>e</sup> 95% CI.<br/>
<sup>f</sup>  Soft Gelatin Capsule.<br/>
<sup>g</sup>  Tenofovir disoproxil fumarate.<br/>
<sup>h</sup>  90% CI not available.<br/>
<sup>i</sup>  Relative to steady-state administration of voriconazole (400 mg for 1 day, then 200 mg po q12h for 2 days).<br/>
<sup>j</sup>  Not available because of insufficient data.<br/>NA = not available.</td>
</tr>
</tfoot>
<tbody>
<tr>
<td stylecode="Toprule " valign="bottom"></td>
<td stylecode="Toprule " valign="bottom"></td>
<td stylecode="Toprule " valign="bottom"></td>
<td stylecode="Toprule " valign="bottom"></td>
<td align="center" colspan="3" stylecode="Toprule " valign="bottom">
<paragraph>
<content stylecode="bold">Coadministered Drug</content>
<br/>
<content stylecode="bold">(mean % change)</content>
</paragraph>
</td>
</tr>
<tr>
<td stylecode="Botrule " valign="bottom">
<paragraph>
<content stylecode="bold">Coadministered Drug</content>
</paragraph>
</td>
<td align="center" stylecode="Botrule " valign="bottom">
<paragraph>
<content stylecode="bold">Dose</content>
</paragraph>
</td>
<td align="center" stylecode="Botrule " valign="bottom">
<paragraph>
<content stylecode="bold">Efavirenz Dose</content>
</paragraph>
</td>
<td align="center" stylecode="Botrule " valign="bottom">
<paragraph>
<content stylecode="bold">Number of Subjects</content>
</paragraph>
</td>
<td align="center" stylecode="Toprule " valign="bottom">
<paragraph>
<content stylecode="bold">C<sub>max</sub>
</content>
<br/>
<content stylecode="bold">(90% CI)</content>
</paragraph>
</td>
<td align="center" stylecode="Toprule " valign="bottom">
<paragraph>
<content stylecode="bold">AUC</content>
<br/>
<content stylecode="bold">(90% CI)</content>
</paragraph>
</td>
<td align="center" stylecode="Toprule " valign="bottom">
<paragraph>
<content stylecode="bold">C<sub>min</sub>
</content>
<br/>
<content stylecode="bold">(90% CI)</content>
</paragraph>
</td>
</tr>
<tr>
<td stylecode="Toprule ">
<paragraph>Atazanavir</paragraph>
</td>
<td stylecode="Toprule ">
<paragraph>400 mg qd with a light meal d 1-20</paragraph>
</td>
<td stylecode="Toprule ">
<paragraph>600 mg qd with a light meal d 7-20</paragraph>
</td>
<td align="center" stylecode="Toprule ">
<paragraph>27</paragraph>
</td>
<td align="center" stylecode="Toprule ">
<paragraph>↓ 59%<br/>(49-67%)</paragraph>
</td>
<td align="center" stylecode="Toprule ">
<paragraph>↓ 74%<br/>(68-78%)</paragraph>
</td>
<td align="center" stylecode="Toprule ">
<paragraph>↓ 93%<br/>(90-95%)</paragraph>
</td>
</tr>
<tr>
<td>
<paragraph> </paragraph>
</td>
<td>
<paragraph>400 mg qd d 1-6, then 300 mg qd d 7-20 with ritonavir 100 mg qd and a light meal</paragraph>
</td>
<td>
<paragraph>600 mg qd 2 h after atazanavir and ritonavir d 7-20</paragraph>
</td>
<td align="center">
<paragraph>13</paragraph>
</td>
<td align="center">
<paragraph>↑ 14%<sup>a</sup>
<br/>(↓ 17-↑ 58%)</paragraph>
</td>
<td align="center">
<paragraph>↑ 39%<sup>a</sup>
<br/>(2-88%)</paragraph>
</td>
<td align="center">
<paragraph>↑ 48%<sup>a</sup>
<br/>(24-76%)</paragraph>
</td>
</tr>
<tr>
<td stylecode="Botrule ">
<paragraph> </paragraph>
</td>
<td stylecode="Botrule ">
<paragraph>300 mg qd/ritonavir 100 mg qd d 1-10 (pm), then 400 mg qd/ritonavir 100 mg qd d 11-24 (pm) (simultaneous with efavirenz)</paragraph>
</td>
<td stylecode="Botrule ">
<paragraph>600 mg qd with a light snack d 11-24 (pm)</paragraph>
</td>
<td align="center" stylecode="Botrule ">
<paragraph>14</paragraph>
</td>
<td align="center" stylecode="Botrule ">
<paragraph>↑ 17%<br/>(8-27%)</paragraph>
</td>
<td align="center" stylecode="Botrule ">
<paragraph>↔</paragraph>
</td>
<td align="center" stylecode="Botrule ">
<paragraph>↓ 42%<br/>(31-51%)</paragraph>
</td>
</tr>
<tr>
<td stylecode="Toprule ">
<paragraph>Indinavir</paragraph>
</td>
<td stylecode="Toprule ">
<paragraph>1000 mg q8h × 10 days</paragraph>
</td>
<td stylecode="Toprule ">
<paragraph>600 mg qd × 10 days</paragraph>
</td>
<td align="center" stylecode="Toprule ">
<paragraph>20</paragraph>
</td>
<td colspan="3" stylecode="Toprule ">
<paragraph> </paragraph>
</td>
</tr>
<tr>
<td>
<paragraph> </paragraph>
</td>
<td colspan="3">
<paragraph>After morning dose</paragraph>
</td>
<td align="center">
<paragraph>↔<sup>b</sup>
</paragraph>
</td>
<td align="center">
<paragraph>↓ 33%<sup>b</sup>
<br/>(26-39%)</paragraph>
</td>
<td align="center">
<paragraph>↓ 39%<sup>b</sup>
<br/>(24-51%)</paragraph>
</td>
</tr>
<tr>
<td>
<paragraph> </paragraph>
</td>
<td colspan="3">
<paragraph>After afternoon dose</paragraph>
</td>
<td align="center">
<paragraph>↔<sup>b</sup>
</paragraph>
</td>
<td align="center">
<paragraph>↓ 37%<sup>b</sup>
<br/>(26-46%)</paragraph>
</td>
<td align="center">
<paragraph>↓ 52%<sup>b</sup>
<br/>(47-57%)</paragraph>
</td>
</tr>
<tr>
<td stylecode="Botrule ">
<paragraph> </paragraph>
</td>
<td colspan="3" stylecode="Botrule ">
<paragraph>After evening dose</paragraph>
</td>
<td align="center" stylecode="Botrule ">
<paragraph>↓ 29%<sup>b</sup>
<br/>(11-43%)</paragraph>
</td>
<td align="center" stylecode="Botrule ">
<paragraph>↓ 46%<sup>b</sup>
<br/>(37-54%)</paragraph>
</td>
<td align="center" stylecode="Botrule ">
<paragraph>↓ 57%<sup>b</sup>
<br/>(50-63%)</paragraph>
</td>
</tr>
<tr>
<td stylecode="Toprule ">
<paragraph>Lopinavir/<br/>   ritonavir</paragraph>
</td>
<td stylecode="Toprule ">
<paragraph>400/100 mg capsule<br/>q12h × 9 days</paragraph>
</td>
<td stylecode="Toprule ">
<paragraph>600 mg qd × 9 days</paragraph>
</td>
<td align="center" stylecode="Toprule ">
<paragraph>11,7<sup>c</sup>
</paragraph>
</td>
<td align="center" stylecode="Toprule ">
<paragraph>↔<sup>d</sup>
</paragraph>
</td>
<td align="center" stylecode="Toprule ">
<paragraph>↓ 19%<sup>d</sup>
<br/>(↓ 36-↑ 3%)</paragraph>
</td>
<td align="center" stylecode="Toprule ">
<paragraph>↓ 39%<sup>d</sup>
<br/>(3-62%)</paragraph>
</td>
</tr>
<tr>
<td>
<paragraph> </paragraph>
</td>
<td>
<paragraph>500/125 mg tablet q12h × 10 days with efavirenz compared to 400/100 mg q12h alone</paragraph>
</td>
<td>
<paragraph>600 mg qd × 9 days</paragraph>
</td>
<td align="center">
<paragraph>19</paragraph>
</td>
<td align="center">
<paragraph>↑ 12%<sup>d</sup>
<br/>(2-23%)</paragraph>
</td>
<td align="center">
<paragraph>↔<sup>d</sup>
</paragraph>
</td>
<td align="center">
<paragraph>↓ 10%<sup>d</sup>
<br/>(↓ 22-↑ 4%)</paragraph>
</td>
</tr>
<tr>
<td stylecode="Botrule ">
<paragraph> </paragraph>
</td>
<td stylecode="Botrule ">
<paragraph>600/150 mg tablet q12h × 10 days with efavirenz compared to 400/100 mg q12h alone</paragraph>
</td>
<td stylecode="Botrule ">
<paragraph>600 mg qd × 9 days</paragraph>
</td>
<td align="center" stylecode="Botrule ">
<paragraph>23</paragraph>
</td>
<td align="center" stylecode="Botrule ">
<paragraph>↑ 36%<sup>d</sup>
<br/>(28-44%)</paragraph>
</td>
<td align="center" stylecode="Botrule ">
<paragraph>↑ 36%<sup>d</sup>
<br/>(28-44%)</paragraph>
</td>
<td align="center" stylecode="Botrule ">
<paragraph>↑ 32%<sup>d</sup>
<br/>(21-44%)</paragraph>
</td>
</tr>
<tr>
<td stylecode="Toprule ">
<paragraph>Nelfinavir</paragraph>
</td>
<td stylecode="Toprule ">
<paragraph>750 mg q8h × 7 days</paragraph>
</td>
<td stylecode="Toprule ">
<paragraph>600 mg qd × 7 days</paragraph>
</td>
<td align="center" stylecode="Toprule ">
<paragraph>10</paragraph>
</td>
<td align="center" stylecode="Toprule ">
<paragraph>↑ 21%<br/>(10-33%)</paragraph>
</td>
<td align="center" stylecode="Toprule ">
<paragraph>↑ 20%<br/>(8-34%)</paragraph>
</td>
<td align="center" stylecode="Toprule ">
<paragraph>↔</paragraph>
</td>
</tr>
<tr>
<td stylecode="Botrule ">
<paragraph>   Metabolite<br/>      AG-1402</paragraph>
</td>
<td colspan="3" stylecode="Botrule ">
<paragraph> </paragraph>
</td>
<td align="center" stylecode="Botrule ">
<paragraph>↓ 40%<br/>(30-48%)</paragraph>
</td>
<td align="center" stylecode="Botrule ">
<paragraph>↓ 37%<br/>(25-48%)</paragraph>
</td>
<td align="center" stylecode="Botrule ">
<paragraph>↓ 43%<br/>(21-59%)</paragraph>
</td>
</tr>
<tr>
<td stylecode="Toprule ">
<paragraph>Ritonavir</paragraph>
</td>
<td stylecode="Toprule ">
<paragraph>500 mg q12h × 8 days</paragraph>
</td>
<td stylecode="Toprule ">
<paragraph>600 mg qd × 10 days</paragraph>
</td>
<td align="center" stylecode="Toprule ">
<paragraph>11</paragraph>
</td>
<td colspan="3" stylecode="Toprule ">
<paragraph> </paragraph>
</td>
</tr>
<tr>
<td>
<paragraph> </paragraph>
</td>
<td colspan="3">
<paragraph>   After AM dose</paragraph>
</td>
<td align="center">
<paragraph>↑ 24%<br/>(12-38%)</paragraph>
</td>
<td align="center">
<paragraph>↑ 18%<br/>(6-33%)</paragraph>
</td>
<td align="center">
<paragraph>↑ 42%<br/>(9-86%)<sup>e</sup>
</paragraph>
</td>
</tr>
<tr>
<td stylecode="Botrule ">
<paragraph> </paragraph>
</td>
<td colspan="3" stylecode="Botrule ">
<paragraph>   After PM dose</paragraph>
</td>
<td align="center" stylecode="Botrule ">
<paragraph>↔</paragraph>
</td>
<td align="center" stylecode="Botrule ">
<paragraph>↔</paragraph>
</td>
<td align="center" stylecode="Botrule ">
<paragraph>↑ 24%<br/>(3-50%)<sup>e</sup>
</paragraph>
</td>
</tr>
<tr>
<td stylecode="Toprule Botrule ">
<paragraph>Saquinavir<br/>   SGC<sup>f</sup>
</paragraph>
</td>
<td stylecode="Toprule Botrule ">
<paragraph>1200 mg q8h × 10 days</paragraph>
</td>
<td stylecode="Toprule Botrule ">
<paragraph>600 mg qd × 10 days</paragraph>
</td>
<td align="center" stylecode="Toprule Botrule ">
<paragraph>12</paragraph>
</td>
<td align="center" stylecode="Toprule Botrule ">
<paragraph>↓ 50%<br/>(28-66%)</paragraph>
</td>
<td align="center" stylecode="Toprule Botrule ">
<paragraph>↓ 62%<br/>(45-74%)</paragraph>
</td>
<td align="center" stylecode="Toprule Botrule ">
<paragraph>↓ 56%<br/>(16-77%)<sup>e</sup>
</paragraph>
</td>
</tr>
<tr>
<td stylecode="Toprule Botrule ">
<paragraph>Lamivudine</paragraph>
</td>
<td stylecode="Toprule Botrule ">
<paragraph>150 mg q12h × 14 days</paragraph>
</td>
<td stylecode="Toprule Botrule ">
<paragraph>600 mg qd × 14 days</paragraph>
</td>
<td align="center" stylecode="Toprule Botrule ">
<paragraph>9</paragraph>
</td>
<td align="center" stylecode="Toprule Botrule ">
<paragraph>↔</paragraph>
</td>
<td align="center" stylecode="Toprule Botrule ">
<paragraph>↔</paragraph>
</td>
<td align="center" stylecode="Toprule Botrule ">
<paragraph>↑ 265%<br/>(37-873%)</paragraph>
</td>
</tr>
<tr>
<td stylecode="Toprule Botrule ">
<paragraph>Tenofovir<sup>g</sup>
</paragraph>
</td>
<td stylecode="Toprule Botrule ">
<paragraph>300 mg qd</paragraph>
</td>
<td stylecode="Toprule Botrule ">
<paragraph>600 mg qd × 14 days</paragraph>
</td>
<td align="center" stylecode="Toprule Botrule ">
<paragraph>29</paragraph>
</td>
<td align="center" stylecode="Toprule Botrule ">
<paragraph>↔</paragraph>
</td>
<td align="center" stylecode="Toprule Botrule ">
<paragraph>↔</paragraph>
</td>
<td align="center" stylecode="Toprule Botrule ">
<paragraph>↔</paragraph>
</td>
</tr>
<tr>
<td stylecode="Toprule Botrule ">
<paragraph>Zidovudine</paragraph>
</td>
<td stylecode="Toprule Botrule ">
<paragraph>300 mg q12h × 14 days</paragraph>
</td>
<td stylecode="Toprule Botrule ">
<paragraph>600 mg qd × 14 days</paragraph>
</td>
<td align="center" stylecode="Toprule Botrule ">
<paragraph>9</paragraph>
</td>
<td align="center" stylecode="Toprule Botrule ">
<paragraph>↔</paragraph>
</td>
<td align="center" stylecode="Toprule Botrule ">
<paragraph>↔</paragraph>
</td>
<td align="center" stylecode="Toprule Botrule ">
<paragraph>↑ 225%<br/>(43-640%)</paragraph>
</td>
</tr>
<tr>
<td stylecode="Toprule Botrule ">
<paragraph>Maraviroc</paragraph>
</td>
<td stylecode="Toprule Botrule ">
<paragraph>100 mg bid</paragraph>
</td>
<td stylecode="Toprule Botrule ">
<paragraph>600 mg qd</paragraph>
</td>
<td align="center" stylecode="Toprule Botrule ">
<paragraph>12</paragraph>
</td>
<td align="center" stylecode="Toprule Botrule ">
<paragraph>↓ 51%<br/>(37-62%)</paragraph>
</td>
<td align="center" stylecode="Toprule Botrule ">
<paragraph>↓ 45%<br/>(38-51%)</paragraph>
</td>
<td align="center" stylecode="Toprule Botrule ">
<paragraph>↓ 45%<br/>(28-57%)</paragraph>
</td>
</tr>
<tr>
<td stylecode="Toprule Botrule ">
<paragraph>Raltegravir</paragraph>
</td>
<td stylecode="Toprule Botrule ">
<paragraph>400 mg single dose</paragraph>
</td>
<td stylecode="Toprule Botrule ">
<paragraph>600 mg qd</paragraph>
</td>
<td align="center" stylecode="Toprule Botrule ">
<paragraph>9</paragraph>
</td>
<td align="center" stylecode="Toprule Botrule ">
<paragraph>↓ 36%<br/>(2-59%)</paragraph>
</td>
<td align="center" stylecode="Toprule Botrule ">
<paragraph>↓ 36%<br/>(20-48%)</paragraph>
</td>
<td align="center" stylecode="Toprule Botrule ">
<paragraph>↓ 21%<br/>(↓ 51-↑ 28%)</paragraph>
</td>
</tr>
<tr>
<td stylecode="Toprule Botrule ">
<paragraph>Boceprevir</paragraph>
</td>
<td stylecode="Toprule Botrule ">
<paragraph>800 mg tid × 6 days</paragraph>
</td>
<td stylecode="Toprule Botrule ">
<paragraph>600 mg qd × 16 days</paragraph>
</td>
<td align="center" stylecode="Toprule Botrule ">
<paragraph>NA</paragraph>
</td>
<td align="center" stylecode="Toprule Botrule ">
<paragraph>↓ 8%<br/>(↓ 22-↑ 8%)</paragraph>
</td>
<td align="center" stylecode="Toprule Botrule ">
<paragraph>↓ 19%<br/>(11-25%)</paragraph>
</td>
<td align="center" stylecode="Toprule Botrule ">
<paragraph>↓ 44%<br/>(26-58%)</paragraph>
</td>
</tr>
<tr>
<td stylecode="Toprule Botrule ">
<paragraph>Simeprevir</paragraph>
</td>
<td stylecode="Toprule Botrule ">
<paragraph>150 mg qd × 14 days</paragraph>
</td>
<td stylecode="Toprule Botrule ">
<paragraph>600 mg qd × 14 days</paragraph>
</td>
<td align="center" stylecode="Toprule Botrule ">
<paragraph>23</paragraph>
</td>
<td align="center" stylecode="Toprule Botrule ">
<paragraph>↓ 51%<br/>(↓ 46-↓ 56%)</paragraph>
</td>
<td align="center" stylecode="Toprule Botrule ">
<paragraph>↓ 71%<br/>(↓ 67-↓ 74%)</paragraph>
</td>
<td align="center" stylecode="Toprule Botrule ">
<paragraph>↓ 91%<br/>(↓ 88-↓ 92%)</paragraph>
</td>
</tr>
<tr>
<td stylecode="Toprule Botrule ">
<paragraph>Azithromycin</paragraph>
</td>
<td stylecode="Toprule Botrule ">
<paragraph>600 mg single dose</paragraph>
</td>
<td stylecode="Toprule Botrule ">
<paragraph>400 mg qd × 7 days</paragraph>
</td>
<td align="center" stylecode="Toprule Botrule ">
<paragraph>14</paragraph>
</td>
<td align="center" stylecode="Toprule Botrule ">
<paragraph>↑ 22%<br/>(4-42%)</paragraph>
</td>
<td align="center" stylecode="Toprule Botrule ">
<paragraph>↔</paragraph>
</td>
<td align="center" stylecode="Toprule Botrule ">
<paragraph>NA</paragraph>
</td>
</tr>
<tr>
<td stylecode="Toprule ">
<paragraph>Clarithromycin</paragraph>
</td>
<td stylecode="Toprule ">
<paragraph>500 mg q12h × 7 days</paragraph>
</td>
<td stylecode="Toprule ">
<paragraph>400 mg qd × 7 days</paragraph>
</td>
<td align="center" stylecode="Toprule ">
<paragraph>11</paragraph>
</td>
<td align="center" stylecode="Toprule ">
<paragraph>↓ 26%<br/>(15-35%)</paragraph>
</td>
<td align="center" stylecode="Toprule ">
<paragraph>↓ 39%<br/>(30-46%)</paragraph>
</td>
<td align="center" stylecode="Toprule ">
<paragraph>↓ 53%<br/>(42-63%)</paragraph>
</td>
</tr>
<tr>
<td stylecode="Botrule ">
<paragraph>   14-OH metabolite</paragraph>
</td>
<td colspan="3" stylecode="Botrule ">
<paragraph> </paragraph>
</td>
<td align="center" stylecode="Botrule ">
<paragraph>↑ 49%<br/>(32-69%)</paragraph>
</td>
<td align="center" stylecode="Botrule ">
<paragraph>↑ 34%<br/>(18-53%)</paragraph>
</td>
<td align="center" stylecode="Botrule ">
<paragraph>↑ 26%<br/>(9-45%)</paragraph>
</td>
</tr>
<tr>
<td stylecode="Toprule Botrule ">
<paragraph>Fluconazole</paragraph>
</td>
<td stylecode="Toprule Botrule ">
<paragraph>200 mg × 7 days</paragraph>
</td>
<td stylecode="Toprule Botrule ">
<paragraph>400 mg qd × 7 days</paragraph>
</td>
<td align="center" stylecode="Toprule Botrule ">
<paragraph>10</paragraph>
</td>
<td align="center" stylecode="Toprule Botrule ">
<paragraph>↔</paragraph>
</td>
<td align="center" stylecode="Toprule Botrule ">
<paragraph>↔</paragraph>
</td>
<td align="center" stylecode="Toprule Botrule ">
<paragraph>↔</paragraph>
</td>
</tr>
<tr>
<td stylecode="Toprule ">
<paragraph>Itraconazole</paragraph>
</td>
<td stylecode="Toprule ">
<paragraph>200 mg q12h × 28 days</paragraph>
</td>
<td stylecode="Toprule ">
<paragraph>600 mg qd × 14 days</paragraph>
</td>
<td align="center" stylecode="Toprule ">
<paragraph>18</paragraph>
</td>
<td align="center" stylecode="Toprule ">
<paragraph>↓ 37%<br/>(20-51%)</paragraph>
</td>
<td align="center" stylecode="Toprule ">
<paragraph>↓ 39%<br/>(21-53%)</paragraph>
</td>
<td align="center" stylecode="Toprule ">
<paragraph>↓ 44%<br/>(27-58%)</paragraph>
</td>
</tr>
<tr>
<td stylecode="Botrule ">
<paragraph>   Hydroxy-itraconazole</paragraph>
</td>
<td colspan="3" stylecode="Botrule ">
<paragraph> </paragraph>
</td>
<td align="center" stylecode="Botrule ">
<paragraph>↓ 35%<br/>(12-52%)</paragraph>
</td>
<td align="center" stylecode="Botrule ">
<paragraph>↓ 37%<br/>(14-55%)</paragraph>
</td>
<td align="center" stylecode="Botrule ">
<paragraph>↓ 43%<br/>(18-60%)</paragraph>
</td>
</tr>
<tr>
<td stylecode="Toprule Botrule ">
<paragraph>Posaconazole</paragraph>
</td>
<td stylecode="Toprule Botrule ">
<paragraph>400 mg (oral suspension) bid × 10 and 20 days</paragraph>
</td>
<td stylecode="Toprule Botrule ">
<paragraph>400 mg qd × 10 and 20 days</paragraph>
</td>
<td align="center" stylecode="Toprule Botrule ">
<paragraph>11</paragraph>
</td>
<td align="center" stylecode="Toprule Botrule ">
<paragraph>↓ 45%<br/>(34-53%)</paragraph>
</td>
<td align="center" stylecode="Toprule Botrule ">
<paragraph>↓ 50%<br/>(40-57%)</paragraph>
</td>
<td align="center" stylecode="Toprule Botrule ">
<paragraph>NA</paragraph>
</td>
</tr>
<tr>
<td stylecode="Toprule Botrule ">
<paragraph>Rifabutin</paragraph>
</td>
<td stylecode="Toprule Botrule ">
<paragraph>300 mg qd × 14 days</paragraph>
</td>
<td stylecode="Toprule Botrule ">
<paragraph>600 mg qd × 14 days</paragraph>
</td>
<td align="center" stylecode="Toprule Botrule ">
<paragraph>9</paragraph>
</td>
<td align="center" stylecode="Toprule Botrule ">
<paragraph>↓ 32%<br/>(15-46%)</paragraph>
</td>
<td align="center" stylecode="Toprule Botrule ">
<paragraph>↓ 38%<br/>(28-47%)</paragraph>
</td>
<td align="center" stylecode="Toprule Botrule ">
<paragraph>↓ 45%<br/>(31-56%)</paragraph>
</td>
</tr>
<tr>
<td stylecode="Toprule ">
<paragraph>Voriconazole</paragraph>
</td>
<td stylecode="Toprule ">
<paragraph>400 mg po q12h × 1 day, then 200 mg po q12h × 8 days</paragraph>
</td>
<td stylecode="Toprule ">
<paragraph>400 mg qd × 9 days</paragraph>
</td>
<td align="center" stylecode="Toprule ">
<paragraph>NA</paragraph>
</td>
<td align="center" stylecode="Toprule ">
<paragraph>↓ 61%<sup>h</sup>
</paragraph>
</td>
<td align="center" stylecode="Toprule ">
<paragraph>↓ 77%<sup>h</sup>
</paragraph>
</td>
<td align="center" stylecode="Toprule ">
<paragraph>NA</paragraph>
</td>
</tr>
<tr>
<td>
<paragraph> </paragraph>
</td>
<td>
<paragraph>300 mg po q12h days 2-7</paragraph>
</td>
<td>
<paragraph>300 mg qd × 7 days</paragraph>
</td>
<td align="center">
<paragraph>NA</paragraph>
</td>
<td align="center">
<paragraph>↓ 36%<sup>i</sup>
<br/>(21-49%)</paragraph>
</td>
<td align="center">
<paragraph>↓ 55%<sup>i</sup>
<br/>(45-62%)</paragraph>
</td>
<td align="center">
<paragraph>NA</paragraph>
</td>
</tr>
<tr>
<td stylecode="Botrule ">
<paragraph> </paragraph>
</td>
<td stylecode="Botrule ">
<paragraph>400 mg po q12h days 2-7</paragraph>
</td>
<td stylecode="Botrule ">
<paragraph>300 mg qd × 7 days</paragraph>
</td>
<td align="center" stylecode="Botrule ">
<paragraph>NA</paragraph>
</td>
<td align="center" stylecode="Botrule ">
<paragraph>↑ 23%<sup>i</sup>
<br/>(↓ 1-↑ 53%)</paragraph>
</td>
<td align="center" stylecode="Botrule ">
<paragraph>↓ 7%<sup>i</sup>
<br/>(↓ 23-↑ 13%)</paragraph>
</td>
<td align="center" stylecode="Botrule ">
<paragraph>NA</paragraph>
</td>
</tr>
<tr>
<td stylecode="Toprule ">
<paragraph>Artemether/lumefantrine</paragraph>
</td>
<td stylecode="Toprule ">
<paragraph>Artemether 20 mg/lumefantrine 120 mg tablets (6 4-tablet doses over 3 days)</paragraph>
</td>
<td stylecode="Toprule ">
<paragraph>600 mg qd × 26 days</paragraph>
</td>
<td align="center" stylecode="Toprule ">
<paragraph>12</paragraph>
</td>
<td stylecode="Toprule "></td>
<td stylecode="Toprule "></td>
<td stylecode="Toprule "></td>
</tr>
<tr>
<td>
<paragraph>Artemether</paragraph>
</td>
<td></td>
<td></td>
<td></td>
<td align="center">
<paragraph>↓ 21%</paragraph>
</td>
<td align="center">
<paragraph>↓ 51%</paragraph>
</td>
<td align="center">
<paragraph>NA</paragraph>
</td>
</tr>
<tr>
<td>
<paragraph>dihydroartemisinin</paragraph>
</td>
<td></td>
<td></td>
<td></td>
<td align="center">
<paragraph>↓ 38%</paragraph>
</td>
<td align="center">
<paragraph>↓ 46%</paragraph>
</td>
<td align="center">
<paragraph>NA</paragraph>
</td>
</tr>
<tr>
<td>
<paragraph>lumefantrine</paragraph>
</td>
<td></td>
<td></td>
<td></td>
<td align="center">
<paragraph>↔</paragraph>
</td>
<td align="center">
<paragraph>↓ 21%</paragraph>
</td>
<td align="center">
<paragraph>NA</paragraph>
</td>
</tr>
<tr>
<td stylecode="Toprule ">
<paragraph>Atorvastatin</paragraph>
</td>
<td stylecode="Toprule ">
<paragraph>10 mg qd × 4 days</paragraph>
</td>
<td stylecode="Toprule ">
<paragraph>600 mg qd × 15 days</paragraph>
</td>
<td align="center" stylecode="Toprule ">
<paragraph>14</paragraph>
</td>
<td align="center" stylecode="Toprule ">
<paragraph>↓ 14%<br/>(1-26%)</paragraph>
</td>
<td align="center" stylecode="Toprule ">
<paragraph>↓ 43%<br/>(34-50%)</paragraph>
</td>
<td align="center" stylecode="Toprule ">
<paragraph>↓ 69%<br/>(49-81%)</paragraph>
</td>
</tr>
<tr>
<td stylecode="Botrule ">
<paragraph>   Total active<br/>   (including<br/>   metabolites)</paragraph>
</td>
<td colspan="3" stylecode="Botrule ">
<paragraph> </paragraph>
</td>
<td align="center" stylecode="Botrule ">
<paragraph>↓ 15%<br/>(2-26%)</paragraph>
</td>
<td align="center" stylecode="Botrule ">
<paragraph>↓ 32%<br/>(21-41%)</paragraph>
</td>
<td align="center" stylecode="Botrule ">
<paragraph>↓ 48%<br/>(23-64%)</paragraph>
</td>
</tr>
<tr>
<td stylecode="Toprule Botrule ">
<paragraph>Pravastatin</paragraph>
</td>
<td stylecode="Toprule Botrule ">
<paragraph>40 mg qd × 4 days</paragraph>
</td>
<td stylecode="Toprule Botrule ">
<paragraph>600 mg qd × 15 days</paragraph>
</td>
<td align="center" stylecode="Toprule Botrule ">
<paragraph>13</paragraph>
</td>
<td align="center" stylecode="Toprule Botrule ">
<paragraph>↓ 32%<br/>(↓ 59-↑ 12%)</paragraph>
</td>
<td align="center" stylecode="Toprule Botrule ">
<paragraph>↓ 44%<br/>(26-57%)</paragraph>
</td>
<td align="center" stylecode="Toprule Botrule ">
<paragraph>↓ 19%<br/>(0-35%)</paragraph>
</td>
</tr>
<tr>
<td stylecode="Toprule ">
<paragraph>Simvastatin</paragraph>
</td>
<td stylecode="Toprule ">
<paragraph>40 mg qd × 4 days</paragraph>
</td>
<td stylecode="Toprule ">
<paragraph>600 mg qd × 15 days</paragraph>
</td>
<td align="center" stylecode="Toprule ">
<paragraph>14</paragraph>
</td>
<td align="center" stylecode="Toprule ">
<paragraph>↓ 72%<br/>(63-79%)</paragraph>
</td>
<td align="center" stylecode="Toprule ">
<paragraph>↓ 68%<br/>(62-73%)</paragraph>
</td>
<td align="center" stylecode="Toprule ">
<paragraph>↓ 45%<br/>(20-62%)</paragraph>
</td>
</tr>
<tr>
<td stylecode="Botrule ">
<paragraph>   Total active<br/>   (including<br/>   metabolites)</paragraph>
</td>
<td colspan="3" stylecode="Botrule ">
<paragraph> </paragraph>
</td>
<td align="center" stylecode="Botrule ">
<paragraph>↓ 68%<br/>(55-78%)</paragraph>
</td>
<td align="center" stylecode="Botrule ">
<paragraph>↓ 60%<br/>(52-68%)</paragraph>
</td>
<td align="center" stylecode="Botrule ">
<paragraph>NA<sup>j</sup>
</paragraph>
</td>
</tr>
<tr>
<td stylecode="Toprule ">
<paragraph>Carbamazepine</paragraph>
</td>
<td stylecode="Toprule ">
<paragraph>200 mg qd × 3 days, 200 mg bid × 3 days, then 400 mg qd × 29 days</paragraph>
</td>
<td stylecode="Toprule ">
<paragraph>600 mg qd × 14 days</paragraph>
</td>
<td align="center" stylecode="Toprule ">
<paragraph>12</paragraph>
</td>
<td align="center" stylecode="Toprule ">
<paragraph>↓ 20%<br/>(15-24%)</paragraph>
</td>
<td align="center" stylecode="Toprule ">
<paragraph>↓ 27%<br/>(20-33%)</paragraph>
</td>
<td align="center" stylecode="Toprule ">
<paragraph>↓ 35%<br/>(24-44%)</paragraph>
</td>
</tr>
<tr>
<td stylecode="Botrule ">
<paragraph>Epoxide metabolite</paragraph>
</td>
<td colspan="3" stylecode="Botrule ">
<paragraph> </paragraph>
</td>
<td align="center" stylecode="Botrule ">
<paragraph>↔</paragraph>
</td>
<td align="center" stylecode="Botrule ">
<paragraph>↔</paragraph>
</td>
<td align="center" stylecode="Botrule ">
<paragraph>↓ 13%<br/>(↓ 30-↑ 7%)</paragraph>
</td>
</tr>
<tr>
<td stylecode="Toprule Botrule ">
<paragraph>Cetirizine</paragraph>
</td>
<td stylecode="Toprule Botrule ">
<paragraph>10 mg single dose</paragraph>
</td>
<td stylecode="Toprule Botrule ">
<paragraph>600 mg qd × 10 days</paragraph>
</td>
<td align="center" stylecode="Toprule Botrule ">
<paragraph>11</paragraph>
</td>
<td align="center" stylecode="Toprule Botrule ">
<paragraph>↓ 24%<br/>(18-30%)</paragraph>
</td>
<td align="center" stylecode="Toprule Botrule ">
<paragraph>↔</paragraph>
</td>
<td align="center" stylecode="Toprule Botrule ">
<paragraph>NA</paragraph>
</td>
</tr>
<tr>
<td stylecode="Toprule ">
<paragraph>Diltiazem</paragraph>
</td>
<td stylecode="Toprule ">
<paragraph>240 mg × 21 days</paragraph>
</td>
<td stylecode="Toprule ">
<paragraph>600 mg qd × 14 days</paragraph>
</td>
<td align="center" stylecode="Toprule ">
<paragraph>13</paragraph>
</td>
<td align="center" stylecode="Toprule ">
<paragraph>↓ 60%<br/>(50-68%)</paragraph>
</td>
<td align="center" stylecode="Toprule ">
<paragraph>↓ 69%<br/>(55-79%)</paragraph>
</td>
<td align="center" stylecode="Toprule ">
<paragraph>↓ 63%<br/>(44-75%)</paragraph>
</td>
</tr>
<tr>
<td>
<paragraph>   Desacetyl<br/>   diltiazem</paragraph>
</td>
<td colspan="3">
<paragraph> </paragraph>
</td>
<td align="center">
<paragraph>↓ 64%<br/>(57-69%)</paragraph>
</td>
<td align="center">
<paragraph>↓ 75%<br/>(59-84%)</paragraph>
</td>
<td align="center">
<paragraph>↓ 62%<br/>(44-75%)</paragraph>
</td>
</tr>
<tr>
<td stylecode="Botrule ">
<paragraph>   N-<br/>   monodesmethyl<br/>   diltiazem</paragraph>
</td>
<td colspan="3" stylecode="Botrule ">
<paragraph> </paragraph>
</td>
<td align="center" stylecode="Botrule ">
<paragraph>↓ 28%<br/>(7-44%)</paragraph>
</td>
<td align="center" stylecode="Botrule ">
<paragraph>↓ 37%<br/>(17-52%)</paragraph>
</td>
<td align="center" stylecode="Botrule ">
<paragraph>↓ 37%<br/>(17-52%)</paragraph>
</td>
</tr>
<tr>
<td stylecode="Toprule ">
<paragraph>Ethinyl estradiol/<br/>   Norgestimate</paragraph>
</td>
<td stylecode="Toprule ">
<paragraph>0.035 mg/<br/>0.25 mg × 14 days</paragraph>
</td>
<td stylecode="Toprule ">
<paragraph>600 mg qd × 14 days</paragraph>
</td>
<td stylecode="Toprule "></td>
<td stylecode="Toprule "></td>
<td stylecode="Toprule "></td>
<td stylecode="Toprule "></td>
</tr>
<tr>
<td>
<paragraph>   Ethinyl<br/>   estradiol</paragraph>
</td>
<td colspan="2">
<paragraph> </paragraph>
</td>
<td align="center">
<paragraph>21</paragraph>
</td>
<td align="center">
<paragraph>↔</paragraph>
</td>
<td align="center">
<paragraph>↔</paragraph>
</td>
<td align="center">
<paragraph>↔</paragraph>
</td>
</tr>
<tr>
<td>
<paragraph>   Norelgestromin</paragraph>
</td>
<td colspan="2">
<paragraph> </paragraph>
</td>
<td align="center">
<paragraph>21</paragraph>
</td>
<td align="center">
<paragraph>↓ 46%<br/>(39-52%)</paragraph>
</td>
<td align="center">
<paragraph>↓ 64%<br/>(62-67%)</paragraph>
</td>
<td align="center">
<paragraph>↓ 82%<br/>(79-85%)</paragraph>
</td>
</tr>
<tr>
<td stylecode="Botrule ">
<paragraph>   Levonorgestrel</paragraph>
</td>
<td colspan="2" stylecode="Botrule ">
<paragraph> </paragraph>
</td>
<td align="center" stylecode="Botrule ">
<paragraph>6</paragraph>
</td>
<td align="center" stylecode="Botrule ">
<paragraph>↓ 80%<br/>(77-83%)</paragraph>
</td>
<td align="center" stylecode="Botrule ">
<paragraph>↓ 83%<br/>(79-87%)</paragraph>
</td>
<td align="center" stylecode="Botrule ">
<paragraph>↓ 86%<br/>(80-90%)</paragraph>
</td>
</tr>
<tr>
<td stylecode="Toprule Botrule ">
<paragraph>Lorazepam</paragraph>
</td>
<td stylecode="Toprule Botrule ">
<paragraph>2 mg single dose</paragraph>
</td>
<td stylecode="Toprule Botrule ">
<paragraph>600 mg qd × 10 days</paragraph>
</td>
<td align="center" stylecode="Toprule Botrule ">
<paragraph>12</paragraph>
</td>
<td align="center" stylecode="Toprule Botrule ">
<paragraph>↑ 16%<br/>(2-32%)</paragraph>
</td>
<td align="center" stylecode="Toprule Botrule ">
<paragraph>↔</paragraph>
</td>
<td align="center" stylecode="Toprule Botrule ">
<paragraph>NA</paragraph>
</td>
</tr>
<tr>
<td stylecode="Toprule Botrule ">
<paragraph>Methadone</paragraph>
</td>
<td stylecode="Toprule Botrule ">
<paragraph>Stable<br/>maintenance 35-<br/>100 mg daily</paragraph>
</td>
<td stylecode="Toprule Botrule ">
<paragraph>600 mg qd × 14-21 days</paragraph>
</td>
<td align="center" stylecode="Toprule Botrule ">
<paragraph>11</paragraph>
</td>
<td align="center" stylecode="Toprule Botrule ">
<paragraph>↓ 45%<br/>(25-59%)</paragraph>
</td>
<td align="center" stylecode="Toprule Botrule ">
<paragraph>↓ 52%<br/>(33-66%)</paragraph>
</td>
<td align="center" stylecode="Toprule Botrule ">
<paragraph>NA</paragraph>
</td>
</tr>
<tr>
<td stylecode="Toprule ">
<paragraph>Bupropion</paragraph>
</td>
<td stylecode="Toprule ">
<paragraph>150 mg single dose<br/>(sustained-release)</paragraph>
</td>
<td stylecode="Toprule ">
<paragraph>600 mg qd × 14 days</paragraph>
</td>
<td align="center" stylecode="Toprule ">
<paragraph>13</paragraph>
</td>
<td align="center" stylecode="Toprule ">
<paragraph>↓ 34%<br/>(21-47%)</paragraph>
</td>
<td align="center" stylecode="Toprule ">
<paragraph>↓ 55%<br/>(48-62%)</paragraph>
</td>
<td align="center" stylecode="Toprule ">
<paragraph>NA</paragraph>
</td>
</tr>
<tr>
<td stylecode="Botrule ">
<paragraph>   Hydroxy-<br/>   bupropion</paragraph>
</td>
<td colspan="3" stylecode="Botrule ">
<paragraph> </paragraph>
</td>
<td align="center" stylecode="Botrule ">
<paragraph>↑ 50%<br/>(20-80%)</paragraph>
</td>
<td align="center" stylecode="Botrule ">
<paragraph>↔</paragraph>
</td>
<td align="center" stylecode="Botrule ">
<paragraph>NA</paragraph>
</td>
</tr>
<tr>
<td stylecode="Toprule Botrule ">
<paragraph>Paroxetine</paragraph>
</td>
<td stylecode="Toprule Botrule ">
<paragraph>20 mg qd × 14 days</paragraph>
</td>
<td stylecode="Toprule Botrule ">
<paragraph>600 mg qd × 14 days</paragraph>
</td>
<td align="center" stylecode="Toprule Botrule ">
<paragraph>16</paragraph>
</td>
<td align="center" stylecode="Toprule Botrule ">
<paragraph>↔</paragraph>
</td>
<td align="center" stylecode="Toprule Botrule ">
<paragraph>↔</paragraph>
</td>
<td align="center" stylecode="Toprule Botrule ">
<paragraph>↔</paragraph>
</td>
</tr>
<tr>
<td stylecode="Botrule Toprule ">
<paragraph>Sertraline</paragraph>
</td>
<td stylecode="Botrule Toprule ">
<paragraph>50 mg qd × 14 days</paragraph>
</td>
<td stylecode="Botrule Toprule ">
<paragraph>600 mg qd × 14 days</paragraph>
</td>
<td align="center" stylecode="Botrule Toprule ">
<paragraph>13</paragraph>
</td>
<td align="center" stylecode="Botrule Toprule ">
<paragraph>↓ 29%<br/>(15-40%)</paragraph>
</td>
<td align="center" stylecode="Botrule Toprule ">
<paragraph>↓ 39%<br/>(27-50%)</paragraph>
</td>
<td align="center" stylecode="Botrule Toprule ">
<paragraph>↓ 46%<br/>(31-58%)</paragraph>
</td>
</tr>
</tbody>
</table>